Qiagen NV (QIA) - Financial and Strategic SWOT Analysis Review

April 2021 | 61 pages | ID: QF74FFEAD8FEN
GlobalData

Abstracts

Qiagen NV (QIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Qiagen NV (Qiagen) is a provider of molecular testing solutions. The company’s sample technologies help isolate and process DNA, RNA and proteins from samples such as blood, tissue and other materials; assay technologies to identify the genetic information of a pathogen in a tumor; bioinformatics solutions to analyze and interpret genomic data; and solutions to automate the use of consumables into efficient molecular testing workflows. It serves human healthcare, forensics, veterinary diagnostics, food safety testing, pharmaceutical and biotechnology and life sciences research markets. The company offers products directly and also through a network of independent distributors. It has operations in the Americas, Europe, the Middle East, Africa and Asia-Pacific. Qiagen is headquartered in Venlo, the Netherlands.

Qiagen NV Key Recent Developments

Mar 02,2021: QIAGEN launches QIAcube Connect MDx platform for automated sample processing in diagnostic labs
Feb 22,2021: QIAGEN Expands Supervisory Board With Appointment of a New Member
Feb 18,2021: QIAGEN announces digital partner program with five initial partnerships
Jan 28,2021: QIAGEN adds dPCR platform QIAcuity to growing portfolio of COVID-19 testing solutions for wastewater and mutation testing
Jan 19,2021: QIAGEN adopts GNS Healthcare's Gemini - The in silico Patient across multiple cancers

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Qiagen NV - Key Facts
Qiagen NV - Key Employees
Qiagen NV - Key Employee Biographies
Qiagen NV - Major Products and Services
Qiagen NV - History
Qiagen NV - Company Statement
Qiagen NV - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Company Overview
Qiagen NV - Business Description
Product Category: Consumables and Related Revenues
Overview
Performance
Product Category: Instrumentation
Overview
Performance
Geographical Segment: Americas
Performance
Geographical Segment: Asia Pacific, Japan and Rest of World
Performance
Geographical Segment: Europe, Middle East and Africa
Performance
R&D Overview
Qiagen NV - Corporate Strategy
Qiagen NV - SWOT Analysis
SWOT Analysis - Overview
Qiagen NV - Strengths
Qiagen NV - Weaknesses
Qiagen NV - Opportunities
Qiagen NV - Threats
Qiagen NV - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Qiagen NV, Medical Equipment, Deals By Year, 2015 to YTD 2021
Qiagen NV, Medical Equipment, Deals By Type, 2015 to YTD 2021
Qiagen NV, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Mar 02, 2021: QIAGEN launches QIAcube Connect MDx platform for automated sample processing in diagnostic labs
Feb 22, 2021: QIAGEN Expands Supervisory Board With Appointment of a New Member
Feb 18, 2021: QIAGEN announces digital partner program with five initial partnerships
Jan 28, 2021: QIAGEN adds dPCR platform QIAcuity to growing portfolio of COVID-19 testing solutions for wastewater and mutation testing
Jan 19, 2021: QIAGEN adopts GNS Healthcare's Gemini - The in silico Patient across multiple cancers
Jan 08, 2021: QIAGEN announces appointment of new supervisory Board Member
Dec 08, 2020: Qiagen increases outlook for 2020 and 2021
Nov 23, 2020: Qiagen opens new facilities in Barcelona Science Park to increase action capacity against COVID-19
Nov 19, 2020: Qiagen and BioNTech to develop test for head and neck cancer
Nov 17, 2020: Leading Diagnostics Companies join forces to establish the access to comprehensive genomic profiling coalition

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Qiagen NV, Key Facts
Qiagen NV, Key Employees
Qiagen NV, Key Employee Biographies
Qiagen NV, Major Products and Services
Qiagen NV, History
Qiagen NV, Subsidiaries
Qiagen NV, Joint Venture
Qiagen NV, Key Competitors
Qiagen NV, Ratios based on current share price
Qiagen NV, Annual Ratios
Qiagen NV, Annual Ratios (Cont...1)
Qiagen NV, Annual Ratios (Cont...2)
Qiagen NV, Interim Ratios
Qiagen NV, Medical Equipment, Deals By Year, 2015 to YTD 2021
Qiagen NV, Medical Equipment, Deals By Type, 2015 to YTD 2021
Qiagen NV, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Qiagen NV, Performance Chart (2016 - 2020)
Qiagen NV, Ratio Charts
Qiagen NV, Medical Equipment, Deals By Year, 2015 to YTD 2021
Qiagen NV, Medical Equipment, Deals by Type, 2015 to YTD 2021